Why central nervous system (CNS) innovators should feel emboldened to stay the course.
Despite some daunting and very real near-term challenges, there are good reasons to be optimistic for central nervous system (CNS) innovation to fulfil its promise in the medium term.
In this whitepaper, read about the enablers of CNS breakthrough innovation, the latest outlook on the competitive landscape and CNS market opportunity, and take a deep dive into 4 hot areas of cutting-edge innovation – Alzheimer’s, Parkinson’s, psychedelics and digital therapeutics.
Two Steps Forward, One Step Back: The Long Road to Success in CNS – IQVIA
